Matches in Nanopublications for { ?s ?p "[Thirteen primary NSCLC heterotransplant models were used to test four treatment regimens, including platinum-based chemotherapy with and without bevacizumab (VEGF-neutralizing antibody) or HDGF-H3 (HDGF-neutralizing antibody) and chemotherapy with bevacizumab and HDGF-H3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP769995.RAceNBb6az5u5BMYLxk1DhTBYig_3Q816h-GzsNl3EKZ8130_assertion description "[Thirteen primary NSCLC heterotransplant models were used to test four treatment regimens, including platinum-based chemotherapy with and without bevacizumab (VEGF-neutralizing antibody) or HDGF-H3 (HDGF-neutralizing antibody) and chemotherapy with bevacizumab and HDGF-H3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769995.RAceNBb6az5u5BMYLxk1DhTBYig_3Q816h-GzsNl3EKZ8130_provenance.
- assertion description "[Thirteen primary NSCLC heterotransplant models were used to test four treatment regimens, including platinum-based chemotherapy with and without bevacizumab (VEGF-neutralizing antibody) or HDGF-H3 (HDGF-neutralizing antibody) and chemotherapy with bevacizumab and HDGF-H3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1079519.RAqdu-qC7oxnwnhlg2U7KJZ4Mhw9mDTTAHlEDDMAFS8XI130_assertion description "[Thirteen primary NSCLC heterotransplant models were used to test four treatment regimens, including platinum-based chemotherapy with and without bevacizumab (VEGF-neutralizing antibody) or HDGF-H3 (HDGF-neutralizing antibody) and chemotherapy with bevacizumab and HDGF-H3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1079519.RAqdu-qC7oxnwnhlg2U7KJZ4Mhw9mDTTAHlEDDMAFS8XI130_provenance.